84.00
-6.00
(-6.67%)
As of 9:42:25 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | 1.38B | 1.48B | 5.84B | 6.11B |
| Low Estimate | 1.36B | 1.45B | 5.79B | 5.97B |
| High Estimate | 1.4B | 1.5B | 5.88B | 6.29B |
| Year Ago Sales | 1.55B | 1.55B | 6.03B | 5.84B |
| Sales Growth (year/est) | -10.95% | -4.67% | -3.26% | 4.67% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RB8.F | -- | -- | -- | -- |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 4/8/2025 |
| Maintains | Keybanc: Overweight to Overweight | 4/8/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 4/2/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/26/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/10/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/14/2025 |